双特异抗体接受者的毒性:专注于T细胞激活双特异抗体
1Department of Nephrology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang City, Jiangxi Province, People's Republic of China.
OncoTargets and therapy
|July 15, 2024
概括
双特异性抗体 (BsAbs) 提供了新的癌症治疗方法,但也可能导致损伤. 本综述详细介绍了接受BsAbs,特别是T细胞参与BsAbs的患者毒性的原因,机制和管理.
科学领域:
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫治疗是一种免疫疗法.
背景情况:
- 双特异性抗体 (BsAbs) 代表了癌症治疗的重大进展,改善了复发或耐药患者的治疗结果.
- 新兴的BsAbs临床使用突出了特定的毒性,包括脏副作用.
- 缺乏对接受抗癌BsAbs的患者毒性的系统分析.
研究的目的:
- 系统地审查BsAbs治疗患者损伤的病因,机制,风险因素和治疗选择.
- 提供与BsAbs相关的毒性的全面了解,重点关注T细胞参与的BsAbs.
- 为科医生和瘤学家提供管理BSAbs相关毒性的知识.
主要方法:
- 文献综述侧重于临床试验数据和已发表的研究.
- 对BsAbs接受者的毒性病因,机制和风险因素的分析.
- 综合有关损伤治疗策略的信息.
主要成果:
- 在接受BsAbs.治疗的患者中,毒性是一个新兴的问题.
- 详细介绍了损伤的病因,机制和危险因素,特别是T细胞参与的BsAbs.
- 讨论了管理策略和治疗选择.
结论:
- 虽然BsAbs疗法是有效的,但存在脏副作用的风险.
- 了解T细胞参与BsAbs中的毒性特异机制对于患者管理至关重要.
- 本综述为临床医生管理接受BsAbs的患者提供了必要的知识,特别是T细胞参与的BsAbs.
相关概念视频
01:40Cell-mediated Immune Responses
68.0K
Overview
68.0K
01:27Cytotoxic T Cells-mediated Immune Response
886
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
886